Defective Drugs and Pharmaceutical Litigation
Pharmaceutical litigation involves taking drug companies (and sometimes doctors) to court when the drugs they put on the market are found to be dangerous or defective.
Even when used properly, drugs can be dangerous. That’s why it’s so important for people to be informed of the risks of their prescription medication. In drug lawsuits, attorneys are concerned with three categories of risk:
- Unanticipated risks: These are risks that aren’t discovered until a drug hits the market and patients begin to report problems – either immediately or years later. When the drug has a defective design, anyone who uses it could be at risk.
- Undisclosed risks: These are risks that were known before the drug went to market, but the drug company covered them up in order to get FDA approval. Failure to warn patients of potential problems means they cannot make informed decisions about their health.
- Contamination: Some medications become dangerous because of errors in the manufacturing process, improper storage, or incorrect preparation. Depending on where the problem occurred, different companies could be responsible for causing injury. Defective manufacture puts lives at immediate risk.
Dangerous side effects are found with increasing frequency as more and more drugs hit the market. Some of the most recent lawsuits alleging a dangerous prescription drug are for:
- Elmiron: Used to tread interstitial cystitis, a bladder disorder. Studies have shown a correlation between long-term use and vision problems, including blindness.
- Zantac (its active ingredient is ranitidine): It contains NDMA, a likely cancer-causing agent.
- Valsartan: A blood pressure medication that’s been found to contain NDMA.
- Eye drops/artificial tears: Some have been found to be contaminated.
- Tepezza (Teprotumumab): This medication for thyroid eye disease is alleged to cause hearing loss and tinnitus.
- GLP-1 Semaglutides (Ozempic, Wegovy, Rybelsus, Mounjaro): Users say they developed serious stomach problems.
- Singulair: Victims claim mental health side effects.
- Similac and Enfamil: Parents of premature infants claim their babies suffered necrotizing enterocolitis from use of these baby formulas.
- Suboxone (Buprenorphine, Naloxone): Lawsuits claim tooth decay, oral infections, cavities and tooth loss for those using it.
- Benzodiazepines (Xanax and Valium): The risk of addiction and overdose is heightened when these anti-anxiety medications are used in conjunction with painkilling opioids.
- Depo-Provera: Some studies have shown an increased risk of tumors in the tissues that line the brain.
Recalled Medications
The FDA maintains a list of recalled medication. You may have looked for your drug on the list and not found it, but not every dangerous drug is subject to a recall. If you are concerned about a drug you or a family member took, talk with your doctor about it. Then call one of our pharmaceutical litigation attorneys for a free initial consultation: 877-Ted-Lyon / 877-833-5966.
Do You Have a Case?
- Do you have a dangerous drug legal claim?
- Should you try to sue a drug company or your doctor?
The Law Firm of Ted B. Lyon & Associates is uniquely positioned to help people with court cases against drug manufacturers. Our pharmaceutical litigation attorneys have the resources needed to bring large-scale lawsuits. We work with investigators, medical professionals, and forensic experts to prepare your case for court.
Call a Pharmaceutical Litigation Attorney
To schedule a free initial consultation, call The Law Firm of Ted B. Lyon & Associates at 877-Ted-Lyon / 877-833-5966 or contact us via email. We handle drug litigation cases on a contingency fee basis. That means we only earn a legal fee if we win your case. Home and hospital consultations are available if you are unable to visit our office.
Our firm has been recognized in many ways over the years, including selection to the Super Lawyers list and an AV Preeminent Rating* in Martindale-Hubbell’s peer review rating system.
*AV Preeminent is a certification mark of Reed Elsevier Properties Inc., used in accordance with the Martindale-Hubbell certification procedures, standards and policies. Martindale-Hubbell is the facilitator of a peer review rating process. Ratings reflect the confidential opinions of members of the bar and the judiciary. Martindale-Hubbell ratings fall into two categories: legal ability and ethical standards.